• The Innovation Hub located in Songdo, Incheon will encompass a manufacturing facility together with a customer experience lab.
• Operations of the manufacturing facility are anticipated to commence in 2026, with a focus on producing high-quality filtration products.

Cytiva, a global life sciences leader, has opened its first Innovation Hub in Korea, located in the Songdo Bio-cluster in Incheon.  

The new facility is intended to serve as a cornerstone of innovation and excellence, driving advancements in biopharmaceutical manufacturing and meeting the evolving needs of Cytiva customers in Korea and the wider APAC region. 

An opening event on 30 September was attended by key government officials from the Incheon Free Economic Zone Authority (IFEZ), and the Korea Trade‐Investment Promotion Agency (KOTRA). Cytiva leaders and other executives from industry leading companies such as Samsung Biologics, Celltrion, SK BioScience and Lotte Biologics were also present.

Yun Won-sok, Commissioner of the Incheon Free Economic Zone (IFEZ), says: "With Cytiva’s Innovation Hub, Songdo enhances its position as a world bio hub. We will continue to work with Cytiva to explore ways to drive the growth of the domestic bio industry, including the training of bio professionals." 

Jongkyu Yoon, vice president of Samsung Biologics says: “In light of growing demand for biopharmaceuticals, the opening of Cytiva's production facility in Korea is great news for pharmaceutical and biotech companies. I am confident that our close collaboration with Cytiva through this Innovation Hub will significantly boost the competitiveness of our domestic life sciences industry.”

A new era of innovation and collaboration

Spanning approximately 6 100 square meters, the Innovation Hub features a manufacturing facility to deliver the necessary products used in developing therapeutics, and a customer experience lab for product demonstrations.  

 In line with Cytiva’s commitment to sustainability, the facility will adhere to Net-Zero environmental impact standards. This will involve the integration of various sustainable building practices aimed at increasing energy and water efficiencies, achieving zero landfilling of waste, and reducing CO2e emissions. 

Joonho Choi, Commercial General Manager of Cytiva Korea, says: " We anticipate the Innovation Hub will not only help drive growth for our Korean customers, but also play a pivotal role in the APAC biopharmaceutical market. This facility will enhance customer engagement and collaboration, fostering innovation and excellence in the region." 

 Strengthening Korea’s biopharma industry and beyond

This new facility is a key component of Cytiva’s comprehensive strategy to address the increasing demands of the biopharmaceutical industry in Korea and the broader APAC region.  

 By adopting sustainable building practices, Cytiva aims to provide Korean customers with eco-friendly solutions that drive industry growth, benefit the market, and support environmental goals.